EFESO - EFficacy Enterogermina Small Intestinal Bacterial Overgrowth
NCT00331994
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
250
Enrollment
INDUSTRY
Sponsor class
Conditions
Irritable Bowel Syndrome
Interventions
DRUG:
Bacillus clausii
DRUG:
Metronidazole
Sponsor
Sanofi